investorscraft@gmail.com

Intrinsic Value of C'bon Cosmetics Co.,Ltd. (4926.T)

Previous Close¥1,134.00
Intrinsic Value
Upside potential
Previous Close
¥1,134.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

C'bon Cosmetics Co., Ltd. operates in the competitive Japanese cosmetics and personal care industry, specializing in skincare and beauty appliances. The company’s core revenue model revolves around the manufacturing and direct sales of high-margin products such as cleansers, lotions, serums, and makeup bases, alongside quasi-drugs that cater to therapeutic beauty needs. Its vertically integrated approach allows control over production quality and cost efficiency, though it faces stiff competition from both domestic giants like Shiseido and emerging indie brands. C'bon’s market positioning leans toward mid-tier affordability with a focus on efficacy, targeting consumers seeking reliable yet accessible skincare solutions. While the company maintains a niche presence in Japan, its limited international footprint and reliance on domestic demand expose it to demographic shifts, including Japan’s aging population. The beauty appliance segment, though smaller, provides diversification but requires sustained R&D to stay relevant in a tech-driven market.

Revenue Profitability And Efficiency

In FY2024, C'bon reported revenue of ¥8.5 billion but recorded a net loss of ¥26.3 million, reflecting margin pressures amid rising input costs and subdued demand. Operating cash flow remained positive at ¥278 million, though capital expenditures (¥598 million) exceeded operational inflows, indicating aggressive reinvestment. The diluted EPS of -¥6.16 underscores profitability challenges, likely tied to pricing competition and fixed-cost absorption.

Earnings Power And Capital Efficiency

The company’s negative net income and thin operating cash flow relative to revenue suggest constrained earnings power. However, its minimal debt (¥4.2 million) and high cash reserves (¥3.6 billion) provide liquidity to navigate short-term headwinds. Capital efficiency appears suboptimal, with capex outweighing cash generation, signaling potential underutilization of invested capital.

Balance Sheet And Financial Health

C'bon’s balance sheet remains robust, with cash and equivalents covering 855x total debt, eliminating near-term solvency risks. The absence of significant leverage and a conservative financial structure align with its defensive sector, though the net loss highlights operational vulnerabilities. The ¥3.6 billion cash pile offers flexibility for strategic shifts or M&A to revive growth.

Growth Trends And Dividend Policy

Despite profitability struggles, C'bon maintained a dividend of ¥20 per share, signaling commitment to shareholder returns. Top-line growth has stagnated, with revenue flatlining year-over-year, reflecting market saturation. A turnaround would require product innovation or geographic expansion, neither of which is evident in recent capex trends.

Valuation And Market Expectations

At a market cap of ¥4.9 billion, the stock trades at 0.57x revenue, a discount to peers, likely pricing in execution risks. The low beta (0.12) implies minimal correlation to broader markets, typical for niche consumer staples. Investors appear cautious, awaiting proof of operational improvements.

Strategic Advantages And Outlook

C'bon’s strengths lie in its debt-free balance sheet and established domestic brand, but its reliance on a stagnant market and lack of scale are headwinds. The outlook hinges on leveraging its cash reserves for R&D or acquisitions to diversify revenue streams. Without strategic pivots, the company risks continued marginalization in a consolidating industry.

Sources

Company filings, Tokyo Stock Exchange disclosures

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount